These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31918331)

  • 1. The Clinical Management and Outcomes of Pelvic Neuroblastic Tumors.
    Zobel M; Zamora A; Sura A; Wang L; Stein J; Marachelian A; Kim ES
    J Surg Res; 2020 May; 249():8-12. PubMed ID: 31918331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical management and outcomes of cervical neuroblastic tumors.
    Jackson JR; Tran HC; Stein JE; Shimada H; Patel AM; Marachelian A; Kim ES
    J Surg Res; 2016 Jul; 204(1):109-13. PubMed ID: 27451875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic neuroblastoma: low mortality and high morbidity.
    Cruccetti A; Kiely EM; Spitz L; Drake DP; Pritchard J; Pierro A
    J Pediatr Surg; 2000 May; 35(5):724-8. PubMed ID: 10813335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Image-defined risk factor assessment of neurogenic tumors after neoadjuvant chemotherapy is useful for predicting intra-operative risk factors and the completeness of resection.
    Irtan S; Brisse HJ; Minard-Colin V; Schleiermacher G; Galmiche-Rolland L; Le Cossec C; Elie C; Canale S; Michon J; Valteau-Couanet D; Sarnacki S
    Pediatr Blood Cancer; 2015 Sep; 62(9):1543-9. PubMed ID: 25820608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroblastoma: treatment outcome after incomplete resection of primary tumors.
    Moon SB; Park KW; Jung SE; Youn WJ
    Pediatr Surg Int; 2009 Sep; 25(9):789-93. PubMed ID: 19629500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localized pelvic neuroblastoma: excellent survival and low morbidity with tailored therapy--the 10-year experience of the French Society of Pediatric Oncology.
    Leclair MD; Hartmann O; Heloury Y; Fourcade L; Laprie A; Mechinaud F; Munzer C; Rubie H
    J Clin Oncol; 2004 May; 22(9):1689-95. PubMed ID: 15117991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
    Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
    J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized dumbbell neuroblastoma: a study of 25 cases treated between 1982 and 1987 using the same protocol.
    Plantaz D; Hartmann O; Kalifa C; Sainte-Rose C; Lemoine G; Lemerle J
    Med Pediatr Oncol; 1993; 21(4):249-53. PubMed ID: 8469218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of surgery in the treatment of patients with high-risk neuroblastoma who have a poor response to induction chemotherapy.
    Du L; Liu L; Zhang C; Cai W; Wu Y; Wang J; Lv F
    J Pediatr Surg; 2014 Apr; 49(4):528-33. PubMed ID: 24726106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma: A Report From the HR-NBL1/SIOPEN Study.
    Holmes K; Pötschger U; Pearson ADJ; Sarnacki S; Cecchetto G; Gomez-Chacon J; Squire R; Freud E; Bysiek A; Matthyssens LE; Metzelder M; Monclair T; Stenman J; Rygl M; Rasmussen L; Joseph JM; Irtan S; Avanzini S; Godzinski J; Björnland K; Elliott M; Luksch R; Castel V; Ash S; Balwierz W; Laureys G; Ruud E; Papadakis V; Malis J; Owens C; Schroeder H; Beck-Popovic M; Trahair T; Forjaz de Lacerda A; Ambros PF; Gaze MN; McHugh K; Valteau-Couanet D; Ladenstein RL;
    J Clin Oncol; 2020 Sep; 38(25):2902-2915. PubMed ID: 32639845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic neuroblastoma--implications for a new favorable subgroup: a Children's Cancer Group experience.
    Haase GM; O'Leary MC; Stram DO; Lukens JN; Seeger RC; Shimada H; Matthay KK
    Ann Surg Oncol; 1995 Nov; 2(6):516-23. PubMed ID: 8591082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of MYCN status on response of high-risk neuroblastoma to neoadjuvant chemotherapy.
    Yanishevski D; McCarville MB; Doubrovin M; Spiegl HR; Zhao X; Lu Z; Federico SM; Furman WL; Murphy AJ; Davidoff AM
    J Pediatr Surg; 2020 Jan; 55(1):130-134. PubMed ID: 31685267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comprehensive protocol for diagnosis and treatment of childhood neuroblastoma--results of 45 cases].
    Tang JY; Pan C; Chen J; Xu M; Chen J; Xue HL; Gu LJ; Dong R; Ye H; Zhou M; Wang YP
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):770-3. PubMed ID: 17229383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
    Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of Image-Defined Risk Factors for the Extent of Surgical Resection and Clinical Outcome in Patients with Pelvic Neuroblastoma.
    Froeba-Pohl A; von Schweinitz D; Muehling J; Paolini M; Hubertus J
    Eur J Pediatr Surg; 2021 Aug; 31(4):362-366. PubMed ID: 32862422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaplastic large cell neuroblastoma.
    Abramowsky CR; Katzenstein HM; Alvarado CS; Shehata BM
    Pediatr Dev Pathol; 2009; 12(1):1-5. PubMed ID: 18397155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enlarged and prominent nucleoli may be indicative of MYCN amplification: a study of neuroblastoma (Schwannian stroma-poor), undifferentiated/poorly differentiated subtype with high mitosis-karyorrhexis index.
    Kobayashi C; Monforte-Munoz HL; Gerbing RB; Stram DO; Matthay KK; Lukens JN; Seeger RC; Shimada H
    Cancer; 2005 Jan; 103(1):174-80. PubMed ID: 15549714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of early resection of primary neuroblastoma on the survival of children older than 1 year of age with stage 4 disease: the St. Jude Children's Research Hospital Experience.
    McGregor LM; Rao BN; Davidoff AM; Billups CA; Hongeng S; Santana VM; Hill DA; Fuller C; Furman WL
    Cancer; 2005 Dec; 104(12):2837-46. PubMed ID: 16288490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable prognosis for patients 12 to 18 months of age with stage 4 nonamplified MYCN neuroblastoma: a Children's Cancer Group Study.
    Schmidt ML; Lal A; Seeger RC; Maris JM; Shimada H; O'Leary M; Gerbing RB; Matthay KK
    J Clin Oncol; 2005 Sep; 23(27):6474-80. PubMed ID: 16116154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete resection is not required in patients with neuroblastoma under 1 year of age.
    Kaneko M; Iwakawa M; Ikebukuro K; Ohkawa H
    J Pediatr Surg; 1998 Nov; 33(11):1690-4. PubMed ID: 9856897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.